Viewing StudyNCT00077922



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00077922
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2004-02-12

Brief Title: Anti-TacFv-PE38 LMB-2 to Treat Chronic Lymphocytic Leukemia
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Chronic
Leukemia
Lymphocytic
Keywords:
Name View
Neutralizing Antibodies View
LMB-2 View
Chronic Lymphocytic Leukemia View
CLL View
Immunotoxin View
Oncology View
Lymphocytes View
Hematological Disease View
Monoclonal Antibody View